Prognostic impact of mitral L-wave in patients with hypertrophic cardiomyopathy without risk factors for sudden cardiac death-Reference-Cited by-同舟云学术

Prognostic impact of mitral L-wave in patients with hypertrophic cardiomyopathy without risk factors for sudden cardiac death

Published:2019-05-31 Issue:12 Volume:34 Page:2002-2010
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Sugiura Yuki,Morimoto Ryota^ORCID,Aoki Soichiro,Yamaguchi Shogo,Haga Tomoaki,Kuwayama Tasuku,Yokoi Tsuyoshi,Hiraiwa Hiroaki,Kondo Toru,Watanabe Naoki,Kano Naoaki,Fukaya Kenji,Sawamura Akinori,Okumura Takahiro,Murohara Toyoaki

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-019-01440-y.pdf

Reference28 articles.

1. Maron BJ, Maron MS (2013) Hypertrophic cardiomyopathy. Lancet 381:242–255

2. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92:785–789

3. American College of Cardiology Foundation/American Heart Association Task Force on P, American Association for Thoracic S, American Society of E, American Society of Nuclear C, Heart Failure Society of A, Heart Rhythm S, Society for Cardiovascular A, Interventions, Society of Thoracic S, Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 142:e153–203

4. Grossman W (1991) Diastolic dysfunction in congestive heart failure. N Engl J Med 325:1557–1564

5. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED, Vogel RA, Abrams J, Bates ER, Brodie BR, Danias PG, Gregoratos G, Hlatky MA, Hochman JS, Kaul S, Lichtenberg RC, Lindner JR, O’rourke RA, Pohost GM, Schofield RS, Tracy CM, Winters WL, Klein WW, Priori SG, Alonso-Garcia A, Blomström-Lundqvist C, De Backer G, Deckers J, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A (2003) American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 42:1687–1713

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study on Risk Factors for Death from Cardiomyopathy and Effectiveness of Health Information Management;Journal of Healthcare Engineering;2021-12-07

2. Mid-Diastolic Events (L Events): A Critical Review;Journal of Clinical Medicine;2021-11-30

3. Hypertrophic cardiomyopathies requiring more monitoring for less atrial fibrillation-related complications: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY);Clinical Research in Cardiology;2021-05-27

4. Prognostic value of leucine/phenylalanine ratio as an amino acid profile of heart failure;Heart and Vessels;2021-01-22